Computational peptide based vaccine against Merkel cell polyomavirus

Zusatztext

Merkel cell carcinoma is an aggressive highly metastatic skin cancer. Developing an advanced vaccine for MCC that specifically targets the immunogenic proteins, is of vital significance to overcome the devastating disease. Thus, we undertake an emerging immunoinformatics approach in order to design an effective, safe vaccine against Merkel Cell Polyomavirus that will protect humans against this devastating form of cancer.

Autorenportrait

Dr. Mawadda Abd - Elraheem, pharmacist, studied at Ahfad University For Women and received her master degree from Ahfad University in the field of biotechnology, she is a valued researcher, her research interests are in the field of vaccination and cancer immunotherapy. Author of several research articles in international journals.

Weitere Details